These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 33965397)

  • 1. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PYY
    Caffrey A; Lavecchia E; Merkel R; Zhang Y; Chichura KS; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2023 Nov; 239():109686. PubMed ID: 37572954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y
    Merkel R; Moreno A; Zhang Y; Herman R; Ben Nathan J; Zeb S; Rahematpura S; Stecyk K; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neurosci Biobehav Rev; 2021 Dec; 131():1169-1179. PubMed ID: 34715149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of GLP-1 receptors attenuates oxycodone taking and seeking without compromising the antinociceptive effects of oxycodone in rats.
    Zhang Y; Kahng MW; Elkind JA; Weir VR; Hernandez NS; Stein LM; Schmidt HD
    Neuropsychopharmacology; 2020 Feb; 45(3):451-461. PubMed ID: 31581176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 receptor activation in the ventral tegmental area attenuates cocaine seeking in rats.
    Hernandez NS; Ige KY; Mietlicki-Baase EG; Molina-Castro GC; Turner CA; Hayes MR; Schmidt HD
    Neuropsychopharmacology; 2018 Sep; 43(10):2000-2008. PubMed ID: 29497166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, reduces cue- and drug-induced fentanyl seeking in rats.
    Urbanik LA; Acharya NK; Grigson PS
    Brain Res Bull; 2022 Oct; 189():155-162. PubMed ID: 36031011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.
    Milliken BT; Elfers C; Chepurny OG; Chichura KS; Sweet IR; Borner T; Hayes MR; De Jonghe BC; Holz GG; Roth CL; Doyle RP
    J Med Chem; 2021 Jan; 64(2):1127-1138. PubMed ID: 33449689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of glucagon-like peptide-1 receptors in the nucleus accumbens attenuates cocaine seeking in rats.
    Hernandez NS; O'Donovan B; Ortinski PI; Schmidt HD
    Addict Biol; 2019 Mar; 24(2):170-181. PubMed ID: 29226617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA.
    Hernandez NS; Weir VR; Ragnini K; Merkel R; Zhang Y; Mace K; Rich MT; Christopher Pierce R; Schmidt HD
    Mol Psychiatry; 2021 Aug; 26(8):4394-4408. PubMed ID: 33257815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel chimeric multi-agonist peptide (GEP44) reduces energy intake and body weight in male and female diet-induced obese mice in a glucagon-like peptide-1 receptor-dependent manner.
    Blevins JE; Honeycutt MK; Slattery JD; Goldberg M; Rambousek JR; Tsui E; Dodson AD; Shelton KA; Salemeh TS; Elfers CT; Chichura KS; Ashlaw EF; Zraika S; Doyle RP; Roth CL
    Front Endocrinol (Lausanne); 2024; 15():1432928. PubMed ID: 39104812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide.
    Kanoski SE; Rupprecht LE; Fortin SM; De Jonghe BC; Hayes MR
    Neuropharmacology; 2012 Apr; 62(5-6):1916-27. PubMed ID: 22227019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice.
    Díaz-Megido C; Thomsen M
    Psychopharmacology (Berl); 2023 Jun; 240(6):1287-1298. PubMed ID: 37106129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-Like Peptide-1 Receptor Signaling in the Lateral Dorsal Tegmental Nucleus Regulates Energy Balance.
    Reiner DJ; Leon RM; McGrath LE; Koch-Laskowski K; Hahn JD; Kanoski SE; Mietlicki-Baase EG; Hayes MR
    Neuropsychopharmacology; 2018 Feb; 43(3):627-637. PubMed ID: 28920591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs.
    Bornebusch AB; Fink-Jensen A; Wörtwein G; Seeley RJ; Thomsen M
    eNeuro; 2019; 6(2):. PubMed ID: 31058214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exendin-4 improves behaviorial deficits via GLP-1/GLP-1R signaling following partial hepatectomy.
    Zhou Y; Li Z; Cao X; Ma H; White PF; Xu X; Jiang Y; Sun X; Cui Y
    Brain Res; 2019 Mar; 1706():116-124. PubMed ID: 30408479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The glucagon-like peptide-1 receptor agonist, exendin-4, reduces sexual interaction behaviors in a brain site-specific manner in sexually naïve male mice.
    Vestlund J; Jerlhag E
    Horm Behav; 2020 Aug; 124():104778. PubMed ID: 32450068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats.
    Douton JE; Augusto C; Stoltzfus B; Carkaci-Salli N; Vrana KE; Grigson PS
    Behav Pharmacol; 2021 Jun; 32(4):265-277. PubMed ID: 33229892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reductions of food intake and body weight in diet-induced obese rats following chronic treatment with a monomeric peptide multiagonist.
    Elfers CT; Chichura KS; Ashlaw EF; Chepurny OG; Holz GG; Doyle RP; Roth CL
    Clin Nutr; 2024 Jul; 43(7):1782-1790. PubMed ID: 38861891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
    Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
    Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.
    Kanoski SE; Fortin SM; Arnold M; Grill HJ; Hayes MR
    Endocrinology; 2011 Aug; 152(8):3103-12. PubMed ID: 21693680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.